Creative medical technology holdings announces filing of 2022 form 10-k and provides business update

Phoenix , april 4, 2023 /prnewswire/ -- creative medical technology holdings, inc. ("creative medical technology" or the "company" or "we") (nasdaq: celz), a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics, today announced the filing of its form 10-k on march 31, 2023 for the year ended december 31, 2022 (fy 2022) and provided a summary of the progress made in 2022 and thus far in 2023. "2022 was a year of significant clinical, regulatory, and partnership milestones, and our efforts in these areas have continued in earnest during 2023," said timothy warbington, chief executive officer of creative medical technology.
CELZ Ratings Summary
CELZ Quant Ranking